Skip to Menu Skip to Search Contact Us Global Websites & Languages Skip to Content

Mycoplasma
The detection of mycoplasma contamination is of utmost concern in bio-therapeutic and vaccine manufacturing. Now that streamlined assay validation procedures and GMP-validated NAT tests are readily available, these methods can provide manufacturers with confidence in results required in production and batch release of products. The high reproducibility and fast throughput of cutting-edge NAT-based methods reduces the amount of time needed for development, safety testing, and final marketing of novel biotechnology products.

Please complete the form to download your copy.

Fields marked with an asterisk (*) are mandatory.

White paper request form

Are you an SGS client?*

200 characters remaining